Conférence virtuelle

Imaging Markers of Vascular Brain Health : Quantification, Clinical Implications, and Future Directions

Prof Marco Duering
Medical Image Analysis Center (MIAC AG), Department of Biomedical Engineering, University of Basel, Switzerland

Marco Duering is a MD with diverse training backgrounds, ranging from molecular and cellular biology during his doctoral thesis at the Center for Molecular Biology Heidelberg (ZMBH) to bioinformatics and clinical neurology. His clinical neuroscience research uses neuroimaging as the main tool for investigating the connection between vascular brain diseases and cognitive impairment.

Cerebrovascular disease (CVD) manifests through a broad spectrum of mechanisms that negatively impact brain and cognitive health. Yet CVD changes (excluding acute stroke) are insufficiently considered in aging and dementia studies which can lead to an incomplete picture of the etiologies contributing to the burden of cognitive impairment. In this context, the aims of this conference are:

  1. To provide a research update on the current MRI methods that can measure CVD lesions as well as early CVD-related brain injury specifically related to small vessel disease
  2. To discuss the clinical implications and relevance of these CVD imaging markers for cognitive decline, incident dementia, and disease progression in Alzheimer disease, and Alzheimerrelated dementias
  3. To present our perspective on the outlook and challenges that remain in the field.

With the increased research interest in this area, we believe that reliable CVD imaging biomarkers for aging and dementia studies are on the horizon.

Le cycle de conférences MA2 est organisé dans le cadre du DIU et des CU MA2. Le Diplôme Inter-Universitaire de diagnostic et prise en soins des Maladies d’Alzheimer et Apparentées (DIU MA2) est une formation nationale multidisciplinaire parrainée par la Fédération des Centres Mémoire (FCM).

Destinée aux médecins travaillant ou aspirant à travailler en centre mémoire, elle se déroule sur deux ans et 8 séminaires. Chaque séminaire est l’occasion d’une conférence ouverte au grand public. Dans le cadre des Certificats Universitaires CU MA2, le DIU MA2 accueille à chaque séminaire chercheurs ou professionnels de santé intéressés par le diagnostic et la prise en charge des troubles neurocognitifs. DIU et CU MA2 bénéficient du soutien des Fondations Alzheimer et Vaincre Alzheimer depuis leur création en 2015.

→ plus de renseignements sur